Eye Mask Gate: Fenty, Glow Recipe and Huda Beauty Shipped the Same Eye Patch in Five Days
Key Takeaways
Between 17 and 22 September, Fenty Skin, Glow Recipe and Huda Beauty all put forward the same sliced eye patch in the same twist-and-dispense container. A Korean brand had been selling that format since July.
Huda Beauty's founder told ELLE the brands were lied to about exclusivity on the packaging supplier. No shared supplier has been confirmed, and the three formulas are not identical.
Korea's contract manufacturers posted record quarters in Q2 2026 on a widening base of indie brands rather than a handful of conglomerates.
Fenty answered with a meme instead of a formulation claim, and the meme traveled further than any product difference would have.
The lesson is not about who copied whom. It is that packaging and formulation can be bought, which makes the things that cannot be bought the only ones worth building.
What Actually Happened in Eye Mask Gate?
On 17 September, Fenty Skin teased a product it described as a reinvented eye patch delivery system. Dew N Plump Fresh-Sliced Hydrogel Eye Patches sat in an airtight container, and a twist of the base sliced off one fresh patch at a time. The post drew thousands of views and likes, and the comments filled up with people asking where to buy it.
The next day, Glow Recipe showed something that looked like the same object. Its Exopeptide Caffeine Brighten and Depuff Fresh Slices Eye Mask arrived in the same cylindrical tube with the same cutting mechanism, and the brand moved fast to get samples into influencers' hands. By 22 September a creator had posted video of an unopened Huda Beauty Undereye Jelly Patches box, also with a slicing mechanism. Three brands, one format, five days. Call it Eye Mask Gate.
The reason this is more than a good afternoon of jokes is the question it puts in front of every consumer brand that has been treating product innovation as its defense. If the packaging, the mechanism, and the manufacturing can all be bought from the same place by anyone with a purchase order, then what exactly is the brand defending?
Huda Kattan, the founder of Huda Beauty, gave the plain version of events to ELLE: "I think it's pretty obvious that we all got screwed over by the same packaging supplier. Formulas are different, but we were lied to on the exclusivity with the packaging supplier."
That sentence is doing a lot of work. It names three things: a cause, which is the supplier; an injury, which is exclusivity that did not hold; and an alibi, which is that the formulas are not the same. Two of the three are checkable. Glow Recipe founders Sarah Lee and Christine Chang said the packaging is just one part of the equation and that the actives are infused into the hydrogel itself, which is a reasonable claim about a different formula. The shared supplier has not been confirmed by anyone, and the beauty trade press has been careful to say so. The claim that cannot be verified is the one about what was promised in a contract nobody outside the deal has seen.
What is on the record is the sequence. Fenty went first and claimed the format. Glow Recipe had been developing its own version of the same container, which suggests two companies had been sitting on the same idea from the same source without either of them knowing. Huda's product had not launched at all. It was leaked by a creator.
Who Made the Sliced Eye Patch First?
Not any of the three brands in the headlines. Wonder Bath, the skincare arm of the KOSDAQ-listed Korean company CSA Cosmic, has been selling its Slice Serum line since July 2026 in a twist-to-slice container. The mechanism is the one everyone is now arguing about: rotate the base, a fresh jelly slice comes out, wear it as a patch. It comes in three versions, for pore tightening, dark spot toning and volume lifting, with 60 slivers in a container, and it is sold to consumers at a mass-market price rather than a prestige one.
Wonder Bath is not an obscure startup that got lucky. CSA Cosmic, founded in 2006 and listed on the KOSDAQ, developed a patented slice-on-demand mechanism and a 72-hour cold-curing process, and the brand was built by Chosungah, one of Korea's most celebrated makeup artists.
So the format was not invented in a Los Angeles or New York product studio this September. It was in market in Korea two months earlier, sold by a company that has been at this for twenty years and lists Sephora, Watsons, Amazon, Olive Young and Shopee among its channels.
It is worth resisting the framing that this is a scandal. What it describes is how the industry has worked for a long time. Korea has long treated format as a category of its own: the cushion compact, the jelly cleanser that rinses to water, the serum in a stick, the essence you tap from a capsule. Western brands have absorbed those formats one at a time, usually years after they were first sold in Seoul. A four day gap between a Korean launch and three Western ones is not a copycat story. It is an unusually short gap.
Why Does the Korean Supply Chain Sell the Same Innovation to Everyone?
Because that is the business. Korean original design manufacturers develop formulations, textures, packaging concepts, and tooling, and then license or adapt them for multiple clients. Exclusivity, when a brand gets it, is a clause in a contract rather than a property of the supply chain. Korea is unusually good at this because packaging makers, formulators and contract manufacturers sit close enough together to move an idea from drawing to shelf quickly, which is exactly what makes one mechanism appear at four brands in the same season.
The financials make the point bluntly. In the second quarter of 2026, Kolmar Korea posted revenue of KRW 861.3 billion, up 17.9 percent, and operating profit of KRW 110.3 billion, up 50.2 percent, an all-time quarterly record for the company. Cosmax reported revenue of KRW 794.9 billion, up 27.5 percent, with operating profit up 21.3 percent, and its Korean unit crossed KRW 500 billion in quarterly revenue for the first time. Its American unit, long a drag on earnings, recorded its first quarterly profit as revenue rose 79 percent. Kolmar attributed the quarter to the global expansion of indie brands, and described the underlying shift plainly: overseas sales were once dominated by large conglomerates, and a growing number of indie brands are now entering the United States, Europe and Japan at the same time, spreading production orders more widely.
Cosmecca Korea, the third of the group, lifted revenue 39.8 percent to KRW 226.1 billion. Analysts quoted in the Korean press expect the sector to keep growing, with Kolmar on consensus for KRW 3.08 trillion in annual revenue, the first time a Korean cosmetics ODM would pass KRW 3 trillion, and they give the same reason each time: the customer base has widened from a few large brands to hundreds of small ones.
Put those two facts next to each other. The industrial base that let a mid-sized Korean brand put a sliced serum on shelves in July is the same one that put a sliced eye patch into three global brands' launch calendars in September. Both facts have the same cause, and neither is anyone's fault.
Why Did Fenty's Meme Do More Than the Product Could?
On 22 September, Fenty posted a picture of the four containers posed as the Spider-Man pointing meme, with the caption "Pulling up to the function with your hgs in the same fit." Huda Kattan commented "This is too good." Charlotte Parler, co-founder of the skincare brand Dieux, wrote "No one does social like Fenty", which is the highest compliment available in that particular corner of the internet. Glow Recipe replied "Touché" and then took its own dig at the scenario, a "this is fine" cartoon with its own container in flames, captioned to say that it actually loved being in good company alongside brands helmed by women it admired.
Note what Fenty did not do. It did not put out a statement about the supplier. It did not argue that it got there first. It did not claim its formula was better. It accepted the situation in public and converted an accusation that could have hurt it, that it was shipping something anyone can buy, into evidence that it is quick, funny, and unbothered. A defensive press release, drafted carefully over two days, would have produced a worse outcome.
This is reactive marketing, and it works on a condition that is easy to miss. All four brands are founded or run by women, sell to heavily overlapping audiences, and do not compete on price. Nobody had a reason to escalate. Put the same joke in a category where two brands are fighting over one shelf, and it reads as a taunt.
What Is Left to Own When the Supply Chain Is Shared?
Not the format, and increasingly not the formula. A hydrogel patch with peptides and caffeine is now routine bought capacity. A brand with a clear brief and a budget can have one in a season. That leaves three things that are much harder to order from a supplier.
The first is a story only one brand can tell. Starface took the most commoditized product in acne care, a hydrocolloid patch, and made it yellow, star-shaped, and deliberately visible. The formulation was never the product. The decision to make the patch visible is the product, and no contract manufacturer can sell that.
The second is evidence that is expensive to assemble. Tower 28 built its position on three medical seals that competitors cannot simply license, because the constraint is not budget but the clinical and regulatory work standing behind them. A supplier can copy the claim. It cannot copy the file.
The third, and the one that breaks fastest, is the relationship with the customer. Drunk Elephant spent a decade owning a distinct point of view about what skincare should be, sold to Shiseido, and lost control of the story. The product did not change. The position did.
None of this is an argument that the four brands in Eye Mask Gate got it wrong. Three of them handled it well. The point is narrower and less comfortable: the thing they were competing over was never theirs to hold.
What Should Brands Take From Eye Mask Gate?
For an international brand, the practical question is which layer of the product it actually owns. If the answer is the mechanism, the texture or the packaging, that answer is worth checking against the contract before the launch date, not after. The workable discipline is to buy the format from whoever makes it best, then spend the marketing budget on something a supplier cannot replicate: clinical evidence, a community with a reason to show up, or a retail relationship that took years to build.
For Chinese beauty brands looking outward, there is a warning here that runs against part of the current playbook. Being able to produce a viral format faster and cheaper is not an advantage when the same supply chain is selling that format to everyone, including the brands you are trying to displace. The Chinese brands that have traveled well in the past two years have usually competed on something other than the cheapest version of a known product: a retail format nobody else had opened, a price point nobody else could hold, or a cultural story specific enough that it could not be lifted.
The size of this category is also worth keeping in view. Hydrogel eye patches were worth about US$400 million globally in 2025 and are forecast to reach US$875.9 million by 2034, with North America taking roughly 34 percent of the market. Nobody reorganizes a company around that. The reason to watch it is that the category is small and crowded enough to show the mechanics of the whole industry in one week: an innovation arrives from Korea, gets licensed broadly, surfaces at four brands within days, and the winner is decided by who reacts best rather than who got there first.
That is a more useful thing to know than who was first.
Double V is a cross-border operating partner and intelligence house for emerging consumer brands, based in Hong Kong and Shenzhen. We help brands connect China and the world through three businesses: Brand Operation (marketing and distribution for brands on retainer), Brand Incubation (sister company Glam Infinite and our own-built brands), and Industry Intelligence (cross-border research and reports). Talk to our team.
Comments